Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068172 · ClinicalTrials.gov registry record · Phase 1
Study of PI-88 in Patients With Advanced Melanoma
A Phase 1 study, sponsored by Cellxpert Biotechnology.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT00068172 is a Phase 1 study that has completed, run by Cellxpert Biotechnology. The registered enrollment target is 88 participants.
The verdict
NCT00068172, a Phase 1 study, has completed, sponsored by Cellxpert Biotechnology.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether PI-88 is safe and effective in the treatment of advanced melanoma.
Interventions
- DRUG PI-88
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2001-07 |
| Est. Completion | 2007-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068172
The ClinicalTrials.gov registry entry for NCT00068172 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cellxpert Biotechnology, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PI-88 is the first listed.
NCT00068172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068172 about?
NCT00068172 is a clinical study titled "Study of PI-88 in Patients With Advanced Melanoma". The purpose of this study is to determine whether PI-88 is safe and effective in the treatment of advanced melanoma.
What is the current status of trial NCT00068172?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2001-07. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00068172?
The interventions under investigation include: PI-88 (DRUG).
Who is sponsoring clinical trial NCT00068172?
This trial is sponsored by Cellxpert Biotechnology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.